May 29, 2015—Congressional Medicare advisers have released a 34-page, standalone descriptive paper about the 340B drug discount program, less than a month before they give Congress a broader Medicare policy report that will address 340B among other issues.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)